Arkolith/Insider Trading/INTI/Form 4

McNulty James A

See Remarks, 10% OwnerInhibitor Therapeutics, Inc. (INTI) · full profile →Form 4 · filed May 17, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2023Other(J)20.1M—$026.1M
May 5, 2023Other(J)79.6M—$00
May 5, 2023Other(J)398K—$0946K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-013201) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML